Protara Therapeutics, Inc.

Protara Therapeutics, Inc. Estimates – HAM:1KPA
TradingView · 23 Oct 2026
Cantor Fitzgerald reiterates Protara Therapeutics stock rating
Investing.com · 15 Oct 2026
Protara Therapeutics Completes Enrollment of the Phase 2b
GlobeNewswire · 15 Oct 2026
About 80% of U.S. adults who rely on nutrition through a vein lack choline. Protara enrolled 24 in its study.
Stock Titan · 15 Oct 2026
Protara completes enrollment in Phase 2b trial for IV choline
Investing.com · 15 Oct 2026
Protara Therapeutics management to meet with Cantor
TipRanks · 09 Oct 2026
Protara Therapeutics (TARA) Shares Edge Higher, Up 1.37% to $2.59 - PCR Spike
www.siam.in · 08 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.